[18F]FDG PET/CT features for the molecular characterization of primary breast tumors

Lidija Antunovic, Francesca Gallivanone, Martina Sollini, Andrea Sagona, Alessandra Invento, Giulia Manfrinato, Margarita Kirienko, Corrado Tinterri, Arturo Chiti, Isabella Castiglioni

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose: The aim of this study was to evaluate the role of imaging features derived from [18F]FDG-PET/CT to provide in vivo characterization of breast cancer (BC). Methods: Images from 43 patients with a first diagnosis of BC were reviewed. Images were acquired before any treatment. Histological data were derived from pretreatment biopsy or surgical histological specimen; these included tumor type, grade, ER and PgR receptor status, lymphovascular invasion, Ki67 index, HER2 status, and molecular subtype. Standard parameters (SUVmean, TLG, MTV) and advanced imaging features (histogram-based and shape and size features) were evaluated. Univariate analysis, hierarchical clustering analysis, and exact Fisher’s test were used for statistical analysis of data. Imaging-derived metrics were reduced evaluating the mutual correlation within group of features as well as the mutual correlation between groups of features to form a signature. Results: A significant correlation was found between some advanced imaging features and the histological type. Different molecular subtypes were characterized by different values of two histogram-based features (median and energy). A significant association was observed between the imaging signature and luminal A and luminal B HER2 negative molecular subtype and also when considering luminal A, luminal B HER2-negative and HER2-positive groups. Similar results were found between the signature and all five molecular subtypes and also when considering the histological types of BC. Conclusions: Our results suggest a complementary role of standard PET imaging parameters and advanced imaging features for the in vivo biological characterization of BC lesions.

Original languageEnglish
Pages (from-to)1945-1954
Number of pages10
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume44
Issue number12
DOIs
Publication statusPublished - Nov 1 2017

Fingerprint

Fluorodeoxyglucose F18
Breast Neoplasms
Statistical Data Interpretation
Cluster Analysis
Biopsy
Neoplasms
Therapeutics

Keywords

  • Breast cancer
  • Radiomics
  • [F]FDG-pet/Ct

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

[18F]FDG PET/CT features for the molecular characterization of primary breast tumors. / Antunovic, Lidija; Gallivanone, Francesca; Sollini, Martina; Sagona, Andrea; Invento, Alessandra; Manfrinato, Giulia; Kirienko, Margarita; Tinterri, Corrado; Chiti, Arturo; Castiglioni, Isabella.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, No. 12, 01.11.2017, p. 1945-1954.

Research output: Contribution to journalArticle

Antunovic, Lidija ; Gallivanone, Francesca ; Sollini, Martina ; Sagona, Andrea ; Invento, Alessandra ; Manfrinato, Giulia ; Kirienko, Margarita ; Tinterri, Corrado ; Chiti, Arturo ; Castiglioni, Isabella. / [18F]FDG PET/CT features for the molecular characterization of primary breast tumors. In: European Journal of Nuclear Medicine and Molecular Imaging. 2017 ; Vol. 44, No. 12. pp. 1945-1954.
@article{64b8907b69e64534adf4bb371dd360b4,
title = "[18F]FDG PET/CT features for the molecular characterization of primary breast tumors",
abstract = "Purpose: The aim of this study was to evaluate the role of imaging features derived from [18F]FDG-PET/CT to provide in vivo characterization of breast cancer (BC). Methods: Images from 43 patients with a first diagnosis of BC were reviewed. Images were acquired before any treatment. Histological data were derived from pretreatment biopsy or surgical histological specimen; these included tumor type, grade, ER and PgR receptor status, lymphovascular invasion, Ki67 index, HER2 status, and molecular subtype. Standard parameters (SUVmean, TLG, MTV) and advanced imaging features (histogram-based and shape and size features) were evaluated. Univariate analysis, hierarchical clustering analysis, and exact Fisher’s test were used for statistical analysis of data. Imaging-derived metrics were reduced evaluating the mutual correlation within group of features as well as the mutual correlation between groups of features to form a signature. Results: A significant correlation was found between some advanced imaging features and the histological type. Different molecular subtypes were characterized by different values of two histogram-based features (median and energy). A significant association was observed between the imaging signature and luminal A and luminal B HER2 negative molecular subtype and also when considering luminal A, luminal B HER2-negative and HER2-positive groups. Similar results were found between the signature and all five molecular subtypes and also when considering the histological types of BC. Conclusions: Our results suggest a complementary role of standard PET imaging parameters and advanced imaging features for the in vivo biological characterization of BC lesions.",
keywords = "Breast cancer, Radiomics, [F]FDG-pet/Ct",
author = "Lidija Antunovic and Francesca Gallivanone and Martina Sollini and Andrea Sagona and Alessandra Invento and Giulia Manfrinato and Margarita Kirienko and Corrado Tinterri and Arturo Chiti and Isabella Castiglioni",
year = "2017",
month = "11",
day = "1",
doi = "10.1007/s00259-017-3770-9",
language = "English",
volume = "44",
pages = "1945--1954",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Berlin Heidelberg",
number = "12",

}

TY - JOUR

T1 - [18F]FDG PET/CT features for the molecular characterization of primary breast tumors

AU - Antunovic, Lidija

AU - Gallivanone, Francesca

AU - Sollini, Martina

AU - Sagona, Andrea

AU - Invento, Alessandra

AU - Manfrinato, Giulia

AU - Kirienko, Margarita

AU - Tinterri, Corrado

AU - Chiti, Arturo

AU - Castiglioni, Isabella

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose: The aim of this study was to evaluate the role of imaging features derived from [18F]FDG-PET/CT to provide in vivo characterization of breast cancer (BC). Methods: Images from 43 patients with a first diagnosis of BC were reviewed. Images were acquired before any treatment. Histological data were derived from pretreatment biopsy or surgical histological specimen; these included tumor type, grade, ER and PgR receptor status, lymphovascular invasion, Ki67 index, HER2 status, and molecular subtype. Standard parameters (SUVmean, TLG, MTV) and advanced imaging features (histogram-based and shape and size features) were evaluated. Univariate analysis, hierarchical clustering analysis, and exact Fisher’s test were used for statistical analysis of data. Imaging-derived metrics were reduced evaluating the mutual correlation within group of features as well as the mutual correlation between groups of features to form a signature. Results: A significant correlation was found between some advanced imaging features and the histological type. Different molecular subtypes were characterized by different values of two histogram-based features (median and energy). A significant association was observed between the imaging signature and luminal A and luminal B HER2 negative molecular subtype and also when considering luminal A, luminal B HER2-negative and HER2-positive groups. Similar results were found between the signature and all five molecular subtypes and also when considering the histological types of BC. Conclusions: Our results suggest a complementary role of standard PET imaging parameters and advanced imaging features for the in vivo biological characterization of BC lesions.

AB - Purpose: The aim of this study was to evaluate the role of imaging features derived from [18F]FDG-PET/CT to provide in vivo characterization of breast cancer (BC). Methods: Images from 43 patients with a first diagnosis of BC were reviewed. Images were acquired before any treatment. Histological data were derived from pretreatment biopsy or surgical histological specimen; these included tumor type, grade, ER and PgR receptor status, lymphovascular invasion, Ki67 index, HER2 status, and molecular subtype. Standard parameters (SUVmean, TLG, MTV) and advanced imaging features (histogram-based and shape and size features) were evaluated. Univariate analysis, hierarchical clustering analysis, and exact Fisher’s test were used for statistical analysis of data. Imaging-derived metrics were reduced evaluating the mutual correlation within group of features as well as the mutual correlation between groups of features to form a signature. Results: A significant correlation was found between some advanced imaging features and the histological type. Different molecular subtypes were characterized by different values of two histogram-based features (median and energy). A significant association was observed between the imaging signature and luminal A and luminal B HER2 negative molecular subtype and also when considering luminal A, luminal B HER2-negative and HER2-positive groups. Similar results were found between the signature and all five molecular subtypes and also when considering the histological types of BC. Conclusions: Our results suggest a complementary role of standard PET imaging parameters and advanced imaging features for the in vivo biological characterization of BC lesions.

KW - Breast cancer

KW - Radiomics

KW - [F]FDG-pet/Ct

UR - http://www.scopus.com/inward/record.url?scp=85023744452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023744452&partnerID=8YFLogxK

U2 - 10.1007/s00259-017-3770-9

DO - 10.1007/s00259-017-3770-9

M3 - Article

AN - SCOPUS:85023744452

VL - 44

SP - 1945

EP - 1954

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 12

ER -